, followed by a sustained secondary activation phase associated with a decline in cellular ATP. The decline of NAD(P)H in the face of elevated PDH activity occurred as a result of respiratory chain activation, which was also manifest in a calcium-dependent increase in the membrane potential and pH gradient components of the proton motive force (PMF). This is the first direct demonstration that Ca 2⍣ -mobilizing hormones increase the PMF in intact cells. Thus, Ca 2⍣ plays an important role in signal transduction from cytosol to mitochondria, with a single [Ca 2⍣ ] m spike evoking a complex series of changes to activate mitochondrial oxidative metabolism.
Introduction
Recent studies have suggested that increases in cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] c ) lead to parallel increases in the concentration of Ca 2ϩ in mitochondria ([Ca 2ϩ ] m ), and that this is important for the stimulation of mitochondrial oxidative metabolism (McCormack et al., 1990; Duchen, 1992; Loew et al., 1994; Rizzuto et al., 1994; Hajnóczky et al., 1995; Rutter et al., 1996b) . In particular, it has been proposed that there is preferential targeting to mitochondria of Ca 2ϩ released from endoplasmic reticulum (ER) stores as a result of the positioning of mitochondrial Ca 2ϩ uptake channels close to ER release sites. Similar results in a number of cell types (Hajnóczky et al., 1995; Rutter et al., 1996b) have supported this hypothesis. In addition to the transmission of cytosolic Ca 2ϩ signals to the mitochondria, it is also apparent that mitochondrial Ca 2ϩ uptake can modulate [Ca 2ϩ ] c dynamics (Nicholls, 1978; Jouaville et al., 1995; Budd and Nicholls, 1996; Simpson and Russell, 1996; Babcock et al., 1997; Hoth et al., 1997) .
One set of targets regulated by the [Ca 2ϩ ] m increases elicited in response to Ca 2ϩ -mobilizing hormones are the intramitochondrial dehydrogenases, pyruvate dehydrogenase (PDH), NAD ϩ -isocitrate dehydrogenase (NAD ϩ -ICDH) and 2-oxoglutarate dehydrogenase (OGDH). Whereas Ca 2ϩ ions interact directly with NAD ϩ -ICDH and OGDH to decrease the K m values for substrates McCormack and Denton, 1979; Rutter, 1990) , the effects of Ca 2ϩ on PDH involve an increase in the active, dephosphorylated form of the enzyme, mediated by a Ca 2ϩ -sensitive phosphatase (Denton et al., 1972 (Denton et al., , 1996 . These findings have led to a model in which the mitochondrial NAD(P)H redox couple is regulated directly by [Ca 2ϩ ] m linked to [Ca 2ϩ ] c changes (Denton and McCormack, 1980; McCormack et al., 1990; Hansford, 1994) . However, each of the dehydrogenases is also sensitive to regulation by metabolites. For example, phosphorylation of the PDH complex is catalyzed by a specific PDH kinase, which is activated by increasing the ratios of ATP/ADP, NADH/NAD ϩ or acetyl CoA/CoA (Reed and Yeaman, 1987) . Similarly, increases in ATP/ ADP and NADH/NAD ϩ ratios directly inhibit NAD ϩ -ICDH and OGDH McCormack and Denton, 1979; Rutter, 1990) .
In earlier studies, we demonstrated in fibroblasts a clear correlation between changes in [Ca 2ϩ ] m and the level of active PDH (Rutter et al., 1996b) . However, studies in single living hepatocytes (Pralong et al., 1994; Hajnóczky et al., 1995) have suggested that the relationship between [Ca 2ϩ ] m and intramitochondrial NAD(P)H is more complex. For example, we found that the close coupling between [Ca 2ϩ ] m and oxidative metabolism assessed through changes in NAD(P)H fluorescence was lost after the initial rapid [Ca 2ϩ ] m -dependent phase of NADP(H) reduction (Hajnóczky et al., 1995) . As a result, sustained redox responses were initiated by transient changes in [Ca 2ϩ ] c (spiking). Paradoxically, the redox responses were not sustained at high agonist doses that caused a sustained elevation in [Ca 2ϩ ] c . This divergence between [Ca 2ϩ ] c signals and activation of mitochondrial metabolism occurs at the level of mitochondrial Ca 2ϩ uptake and not Ca 2ϩ -dependent stimulation of intramitochondrial dehydrogenases. We proposed that efficient and rapid Ca 2ϩ uptake into the mitochondria occurs only during active Ca 2ϩ mobilization from internal stores, which corresponds to the rising phase of the [Ca 2ϩ ] c oscillation (Hajnóczky et al., 1995) . Thus, high agonist doses that generate a sustained increase in [Ca 2ϩ ] c elevate [Ca 2ϩ ] m only transiently . The activation of Ca 2ϩ -sensitive intramitochondrial dehydrogenases would be predicted to follow the changes in [Ca 2ϩ ] m (Hajnóczky et al., 1995) . However, the NAD(P)H reoxidation rate is slow relative to the decline in [Ca 2ϩ ] m (Hajnóczky et al., 1995) . This suggested that intramitochondrial metabolism is regulated by hormones through additional mechanisms, or the activity state of the Ca 2ϩ -sensitive dehydrogenases declines more slowly than [Ca 2ϩ ] m . For example, the slow fall in NADP(H) could be due to a slow rephosphorylation and consequent inactivation of PDH.
The present study was undertaken with two principal aims: (i) to investigate the relationship between [Ca 2ϩ ] m and PDH during a single [Ca 2ϩ ] m spike; and (ii) to analyze the relationship between PDH activation and NAD(P)H changes. Therefore, the level of the active, dephosphorylated form of PDH (PDH a ) has been measured synchronously with pyridine nucleotide redox state following stimulation with a high dose of vasopressin. This hormone, which elicits Ca 2ϩ release through the generation of inositol 1,4,5-trisphosphate (IP 3 ), has been shown previously to activate PDH in suspensions of liver cells and in the perfused liver (Hems et al., 1978; Oviasu and Whitton, 1984) . However, the effects of the hormone on PDH a have not been examined in the attached primary cultures of hepatocytes used to study [Ca 2ϩ ] c , [Ca 2ϩ ] m and NADP(H) responses in single cells. By using Ca 2ϩ -sensitive fluorescent dyes localized to the mitochondria in single-cell measurements, and recombinant targeted aequorins in cell populations, we demonstrate that high doses of vasopressin provoke a sustained rise in [Ca 2ϩ ] c , but a transient increase in [Ca 2ϩ ] m . Analysis of the kinetics of the subsequent changes in PDH a , NAD(P)H and mitochondrial proton motive force (PMF) suggest that Ca 2ϩ -dependent changes in PDH are only one of a number of factors controlling mitochondrial redox changes after a single [Ca 2ϩ ] m spike. Our data indicate that hepatic mitochondria convert a single [Ca 2ϩ ] m spike into prolonged PDH stimulation, followed by increased respiratory chain activity. Interplay between Ca 2ϩ -dependent activation and metabolic feedback regulation of PDH, the citric acid cycle dehydrogenases and the respiratory chain gives rise to the complex pattern of NAD(P)H changes following agonist stimulation. [Ca 2ϩ ] c 'spike' elicited a transient increase in NAD(P)H fluorescence, and that the resulting NAD(P)H oscillations merged to give a sustained elevation of NAD(P)H at high [Ca 2ϩ ] c oscillation frequencies (Hajnóczky et al., 1995) . In order to elucidate the metabolic events underlying these Ca 2ϩ -induced changes in mitochondrial NAD(P)H levels in the present study, it was necessary to establish conditions where changes in [Ca 2ϩ ] c and [Ca 2ϩ ] m occurred synchronously throughout a population of cells. Since submaximal vasopressin concentrations yield asynchronous oscillations in these parameters, we chose a maximal dose of vasopressin that gave a synchronous increase in [Ca 2ϩ ] c , which was then sustained in the entire cell population. Hepatocytes incubated for the PDH assay were cultured in an identical manner, but on polylysine-coated Petri dishes. No differences were observed in the response of [Ca 2ϩ ] c or [Ca 2ϩ ] m to vasopressin challenge for cells plated on polylysinecoated glass or plastic (not shown).
Results

Relationship
As reported previously (Hajnóczky et al., 1995) , 50 nM vasopressin evoked a sustained increase in [Ca 2ϩ ] c , measured with cytosolic fura-2, accompanied by a transient, synchronized increase in [Ca 2ϩ ] m , measured with the mitochondrial rhod-2 ( Figure 1A) . Stimulation of rhod-2-loaded hepatocytes with vasopressin evoked increases in [Ca 2ϩ ] m that could also be detected within single mitochondria, co-localized with the membrane potentialinsensitive dye, Mito Tracker Green (MTG) (Figure 2A ). The increase in [Ca 2ϩ ] m reported by rhod-2 fluorescence had similar kinetics in all of the mitochondria within a single cell, but the relative amplitude was significantly larger in peripheral mitochondria. The mechanism for the larger [Ca 2ϩ ] m increase in peripheral mitochondria is unknown, although it should be noted that the overall density of mitochondria is lower in the cell periphery. The average rhod-2 fluorescence intensity from all mitochondria increased 229 Ϯ 35% after vasopressin stimulation (Ͼ150 mitochondrial measurements/cell; n ϭ 4).
In order to obtain a calibrated measure of [Ca 2ϩ ] m and to confirm that the increase in [Ca 2ϩ ] m was indeed transient, we expressed the recombinant Ca 2ϩ -sensitive photoprotein, aequorin, targeted to mitochondria via the signal sequence of subunit VIII of cytochrome c oxidase (Rizzuto et al., 1992; Rutter et al., 1996a,b) . Immunocytochemical analysis of the distribution of the hemagglutinin (HA) epitope tag of the aequorin construct revealed characteristic and exclusive mitochondrial staining, either in a single optical slice ( Figure 2D ) or after superimposition of multiple slices ( Figure 2E ). Stimulation of mitochondrial aequorin-expressing hepatocytes with 50 nM vasopressin yielded a transient increase in light output, which could be calibrated (Rutter et al., 1993) to reveal a peak increase of [Ca 2ϩ ] m to 1.96 Ϯ 0.22 μM, with a time-to-peak of 13.6 Ϯ 4.0 s (n ϭ 7 separate hepatocyte preparations). [Ca 2ϩ ] m then recovered to near-resting values (Ͻ200 nM) within 2 min. These data confirmed that stimulation of the cells with 50 nM vasopressin produced a single, transient spike in [Ca 2ϩ ] m .
A rapid increase in cellular NAD(P)H fluorescence, which predominantly reflects changes in the mitochondrial NADH in the hepatocytes and perfused liver (Avi-Dor et al., 1962; Sugano et al., 1980; Hajnóczky et al., 1995) , occurred synchronously with the increase in [Ca 2ϩ ] m , but decayed more slowly ( Figure 1B) . We have speculated that this could reflect the activation and deactivation of the PDH complex (Hajnóczky et al., 1995) . We therefore tested this hypothesis directly in synchronized cell populations. As expected, a rapid initial phase of PDH activation [Ca 2ϩ ] m responses in primary cultured rat hepatocytes co-loaded with fura-2 and rhod-2. To improve temporal resolution, fura-2 fluorescence changes were monitored at 380 nm only. Mitochondrial localization of rhod-2 fluorescence signals was confirmed by the addition of the mitochondrial uncoupler, 1799 (5 μg/ml) plus oligomycin (5 μg/ml), (UNC). (B) Effect of maximal vasopressin on mitochondrial NAD(P)H and PDH a activity. NAD(P)H responses were monitored using 360 nm autofluorescence in unloaded hepatocytes. The mean fluorescence signal calculated from all cells in the imaging field was normalized to the peak 360 nm fluorescence intensity obtained after the addition of rotenone (5 μg/ml) plus 10 mM β-hydroxybutyrate (see Figures 5 and  6 ). Mean PDH a activity was measured in triplicate from the same hepatocyte preparation at the indicated time points. PDH a activity is expressed as a percentage of the maximal PDH activity present in the extract. (C) Mean PDH a activity from four different hepatocyte preparations measured in triplicate. The data are expressed as a percentage of PDH a activity prior to vasopressin stimulation. The symbol, † designates PDH a values significantly different from that at time zero (P ഛ0.05).
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followed stimulation with vasopressin, and was correlated with the NAD(P)H rise, achieving a transient plateau after 30 s. This behavior of the PDH complex is consistent with the rapid transfer of Ca 2ϩ from ER Ca 2ϩ stores into mitochondria, as previously proposed Hajnóczky et al., 1995; Rutter et al., 1996b) . However, whereas NAD(P)H fluorescence began to decline to basal levels 60-100 s after stimulation ( Figure 1B) , a second phase of PDH activation then ensued (Figure 1B and C) . This observation raises two questions: (i) since [Ca 2ϩ ] m has declined essentially to basal levels 2 min after stimulation, what mechanism is responsible for the further increase in PDH a ; and (ii) why should NAD(P)H levels begin to fall in the face of increased PDH a ? To investigate question (i), we determined whether other, metabolic factors were responsible for the changes in PDH activity.
[Ca 2⍣ ] m -independent mechanisms of PDH activation In addition to the regulation of PDH phosphate phosphatase by Ca 2ϩ , the phosphorylation state of the PDH complex is regulated by several cofactors that modulate the activity of PDH kinase (Reed and Yeaman, 1987; Denton et al., 1996) . We first tested the possibility that a decrease in acetyl CoA:CoA ratio, which would inactivate PDH kinase and therefore increase PDH a , could occur during the second phase of PDH activation ( Figure 1B and C) . Inhibition of fatty acid oxidation by vasopressin might be expected to result in a decrease in the ratio of acetyl CoA:CoA. We tested this hypothesis by stimulating hepatocytes with vasopressin in the presence of a concentration of D-carnitine sufficient to block the transport of long chain fatty acids across the inner mitochondrial membrane (Figure 3) . The presence of D-carnitine caused an unexpected small decrease in basal PDH a prior to vasopressin challenge, but the extent and kinetics of the subsequent vasopressin-induced activation were unaffected (Figure 3 ). Incubation with L-carnitine to enhance the oxidation of fatty acyl-CoA and increase acetyl-CoA caused the excepted decrease in basal PDH a . However, like D-carnitine, L-carnitine was without effect on the subsequent vasopressin-induced activation of PDH (Figure 3 ). These findings eliminated changes in fatty acid oxidation as a likely cause of the second phase of PDH activation following vasopressin stimulation.
We next tested the role of ATP:ADP changes in altering the level of PDH a ; a fall in this ratio would be predicted to activate the complex by inhibition of PDH kinase activity. As shown in Figure 4A and B, vasopressin stimulation evoked a rapid and sustained decrease in cellular ATP of~15%. Similar behavior has been observed recently in HeLa cells stimulated with another IP 3 -generating agonist, histamine (L.S.Jouaville, C.Bastianutto and R.Rizzuto, unpublished data). Furthermore, vasopressin potentiated the decrease in ATP resulting from treatment with the mitochondrial ATP synthase inhibitor, oligomycin ( Figure 4B ). However, vasopressin stimulation did not potentiate the fall in cellular ATP in the presence of the mitochondrial ATP translocase inhibitor, atractyloside. The kinetics of the vasopressin-induced decrease in the ATP:ADP ratio suggest that this may act in concert with an increase in [Ca 2ϩ ] m to achieve the first phase of PDH 
Hepatocytes were stimulated with 50 nM vasopressin at time zero and PDH a activity assayed at the indicated time points. PDH a was measured in triplicate from two hepatocyte preparations. Insert: PDH a normalized to the basal levels of PDH a for each condition. Hepatocytes were stimulated with 50 nM vasopressin at time zero and ATP levels determined at the indicated time points. ATP was assayed in triplicate from four different hepatocyte preparations and normalized to total cellular protein measured in a parallel culture from the same cell preparation. Basal ATP levels were 9.0 Ϯ 2.6 nmol/mg protein. (B) Effect of oligomycin and atractyloside on cellular ATP levels in the presence or absence of 50 nM vasopressin. Hepatocytes were treated for 10 min with either: 50 nM vasopressin (VP); 5 μg/ml oligomycin (OL); vasopressin plus oligomycin (OL ϩ VP); 5 μg/ml atractyloside (AT); or vasopressin plus atractyloside (AT ϩ VP). (C) Effect of mitochondrial ATP synthase and ATP translocase blockers on basal and vasopressin-stimulated PDH a activity. Cultured hepatocytes were incubated in the presence of 50 nM vasopressin (d), 5 μg/ml oligomycin (u), vasopressin plus oligomycin 5 μg/ml (j), atractyloside (n) or vasopressin plus atractyloside (m). PDH a was determined in triplicate at the indicated times (data from two hepatocyte preparations).
4991 activation ( Figure 1B and C). However, it is unlikely that the decrease in cellular ATP content could entirely explain the second phase of PDH activation (beginning~2 min after vasopressin exposure) since, during this time, a new steady-state level of ATP had been achieved. Nevertheless, the slow component of PDH activation closely paralleled the reoxidation of NAD(P)H ( Figure 1B) . Therefore, the decline in NAD(P)H, which would tend to decrease the activity of PDH kinase, may gradually unmask the effect of the rapid decline in ATP. Thus, the second phase of PDH activation can be explained by a sustained fall in mitochondrial ATP, combined with the time-dependent fall in NAD(P)H.
To test further the hypothesis that the sustained changes in the level of PDH a after a vasopressin challenge could be mediated by alterations in intramitochondrial ATP, we examined the effect of oligomycin and atractyloside on vasopressin stimulation of PDH ( Figure 4C ). Oligomycin pre-incubation would be expected to decrease mitochondrial [ATP] , whereas the presence of atractyloside should maintain a high [ATP] m . Inhibition of mitochondrial ATP synthesis dramatically potentiated the effects of vasopressin challenge on the increase in PDH a ( Figure 4C ). In contrast, blockade of mitochondrial ATP:ADP transport with atractyloside entirely prevented the vasopressininduced increase in PDH a ( Figure 4C ). Strikingly, the potentiation by vasopressin of the oligomycin-induced increase in PDH a , and the absence of any effect of vasopressin on PDH a in the presence of atractyloside ( Figure 4C ), matched the effects of vasopressin on ATP levels in the presence of each inhibitor ( Figure 4B ). These data suggest that the second phase of PDH activation can be explained by the combined effect of an increase in cytosolic ATP consumption in the presence of the hormone, resulting in a fall in [ATP] m and a subsequent reoxidation of NAD(P)H.
Role of PDH in the control of mitochondrial NAD(P)H levels after vasopressin stimulation
The fact that NAD(P)H fell in the face of an increase in PDH a during the latter period of vasopressin stimulation ( Figure 1B ) suggested that alterations in PDH activity may not be the primary determinant of NAD(P)H levels. In order to test this hypothesis directly, we examined the response of mitochondrial NAD(P)H to a large increase in the level of PDH a using the specific PDH kinase inhibitor, dichloroacetate (DCA; Whitehouse et al., 1974) . DCA has no effect on the citric acid cycle dehydrogenases, NAD ϩ -ICDH and OGDH. Exposure of hepatocytes to 2 mM DCA for 5 min caused an increase in the proportion of PDH a to 55 Ϯ 2.0% of total activity compared with a control value of 21.0 Ϯ 0.5% (n ϭ 3 separate preparations). Nevertheless, DCA addition caused a partial oxidation of NAD(P)H in the absence of agonist ( Figure 5 ). Moreover, subsequent challenge with 50 nM vasopressin prompted an increase in PDH a to 97.0 Ϯ 6.0% (assayed 60 s after stimulation), and a similar rate and extent of NAD(P) reduction was observed in the presence and absence of DCA ( Figure 5 ). Although pre-activation of PDH with DCA did not grossly perturb the NADP(H) response to vasopressin, DCA pre-treatment resulted in a small decrease in the magnitude of pyridine nucleotide reduction (6.2 Ϯ 1.5%; n Ͼ100 cells from two cell preparations; Figure 5, inset) and an earlier onset of the NAD(P)H reoxidation phase when compared with untreated hepatocytes. These data indicate that the vasopressin-induced increase in PDH a is only one of the mechanisms by which the redox state of the mitochondrial NAD(P)H couple is modified. Furthermore, since the secondary phase of PDH activation is expected to increase NAD(P)H production at a time when NAD(P)H reoxidation is occurring, it is clear that alternative mechanisms of regulation must predominate during this phase.
Mechanisms of NAD(P)H reoxidation
The results described above led us to search for further mechanisms that might be responsible for the late phase decline in NAD(P)H. One possible mechanism is activation of the mitochondrial respiratory chain after hormone stimulation, resulting in an enhanced rate of NAD(P)H oxidation. A transient increase in cellular NAD(P)H fluorescence accompanied by a sustained stimulation of the mitochondrial respiratory rate has been observed in isolated hepatocyte suspensions challenged with a high vasopressin dose (Balaban and Blum, 1982; Quinlan and Halestrap, 1986; Halestrap, 1989; Brown et al., 1990) . Brown et al. (1990) have also shown that β-hydroxybutyrate increases both NAD(P)H and mitochondrial respiratory rate, but not to the same extent as observed during vasopressin stimulation. Evidence that vasopressin increases the rate of NAD(P)H oxidation in cultured hepatocytes was provided by the observation that addition of β-hydroxybutyrate to naive cells caused a sustained increase in NAD(P)H ( Figure 6A ), whereas addition of β-hydroxybutyrate to cells pre-treated with vasopressin caused only a transient increase ( Figure 6B ). The gradual reoxidation of NAD(P)H in the presence of hormone could be explained by a time-dependent increase in respiratory chain activity. When vasopressin was added after β-hydroxybutyrate, the hormone still caused a large increase in NAD(P)H and a significantly faster rate of NAD(P)H reoxidation compared with β-hydroxybutyrate alone ( Figure 6C ). The enhanced rate of NAD(P)H reoxidation could be explained by the ability of Ca 2ϩ -mobilizing hormones to stimulate mitochondrial respiratory chain flux (Quinlan and Halestrap, 1986; Brown et al., 1990; reviewed in Hoek, 1992 ). NAD(P)H reoxidation could not be accounted for by Ca 2ϩ -dependent activation of the malate-aspartate shuttle (Strzelecki et al., 1988; Sugano et al., 1988) , which transfers reducing equivalents into the cytosol, because NAD(P)H reoxidation was unaffected by the transaminase inhibitor aminooxyacetate ( Figure 6D ).
Further evidence that increased respiratory chain activity was responsible for the reoxidation of NAD(P)H comes from the data shown in Figure 7 . Addition of oligomycin to inhibit mitochondrial ATP synthetase, and hence decrease flux through the respiratory chain, caused a substantial increase in the extent of mitochondrial pyridine nucleotide reduction ( Figure 7A ). Subsequent treatment with vasopressin caused a further, sustained increase in redox state in the oligomycin-treated cells. The sustained nature of the NAD(P)H increase suggests that vasopressin does not stimulate its reoxidation when respiratory chain activity is limited by preventing ATP synthesis. However, the lack of NAD(P)H reoxidation could also be explained by activation of the other Ca 2ϩ -sensitive dehydrogenases (NAD ϩ -ICDH and OGDH), which are stimulated allosterically by a fall in intramitochondrial ATP:ADP ratio. Therefore, we used the mitochondrial adenine nucleotide translocase inhibitor atractyloside to inhibit respiratory chain flux whilst maintaining high intramitochondrial ATP:ADP. This agent had no effect on mitochondrial NAD(P)H in the absence of vasopressin but, in common with oligomycin, it converted the transient increase in NAD(P)H usually observed with vasopressin to a sustained response ( Figure 7B ). Under these conditions, control of respiratory chain flux is shifted to the adenine nucleotide translocase, such that respiratory chain activation by vasopressin would not be reflected in enhanced NAD(P)H reoxidation. Figure 7 shows that oligomycin and atractyloside had no effect on basal [Ca 2ϩ Vasopressin-induced elevation of mitochondrial PMF Stimulation of respiratory chain activity independent of energy utilization is expected to result in an increase in the PMF across the inner mitochondrial membrane. The PMF is composed of membrane potential (ΔΨ m ) and pH gradient (ΔpH m ) components. Although it has not been shown for vasopressin, a number of previous studies have suggested that gluconeogenic hormones such as glucagon, α-adrenergic agonists and L-triiodothyronine increase the PMF in hepatocyte suspensions and perfused liver (Prpic et al., 1978; Taylor et al., 1980; Soboll and Scholz, 1986; Halestrap, 1989; Soboll et al., 1992; Soboll, 1993) . However, the measurements of PMF in these studies were carried out in mitochondrial fractions isolated from the cells or tissue subsequent to hormone treatment. In the . NAD(P)H reoxidation rate in control and vasopressin-stimulated hepatocytes. β-Hydroxybutyrate (β-OH) was added to primary cultured hepatocytes either alone (A), after (B) or before (C) the addition of 50 nM vasopressin (VP). In (D), 2 mM aminooxyacetate (AOA), an inhibitor of the malate-aspartate shuttle, was added prior to the addition of β-OH. NAD(P)H responses were monitored using 360 nm excitation, and normalized to the fluorescence intensity obtained after the addition of rotenone (5 μg/ml; Rot). Each trace represents the mean NAD(P)H response of all cells in the imaging field (50-100 cells), and is representative of three or more similar experiments. present work, we have used fluorescent indicators to monitor changes in ΔΨ m and ΔpH m of intact living cells in real-time during stimulation with vasopressin. The cultured hepatocytes were incubated with the weak acid fluorescein, which distributes across the mitochondrial inner membrane according to ΔpH m , or with the potentialsensitive dye, tetramethylrhodamine ethyl ester (TMREE) (Thomas et al., 1991; Loew et al., 1993) . Vasopressin stimulation of single hepatocytes caused a significant and time-dependent increase in both mean fluorescein and TMREE fluorescence intensities, indicating a relative increase in ΔpH m and ΔΨ m ( Figure 8A and B) . The rates of rise of ΔpH m and ΔΨ m after vasopressin stimulation were much slower than the [Ca 2ϩ ] c and [Ca 2ϩ ] m responses, but more closely paralleled the reoxidation of NAD(P)H and the second phase of PDH activation. Increases in mitochondrial PMF were more sustained than the changes in NAD(P)H, but returned towards basal values after prolonged stimulation ( Figure 8B ). Vasopressin-induced changes in PMF do not appear to result from increased supply of reducing equivalents to the respiratory chain, since addition of β-hydroxybutyrate prior to the stimulus had little effect on ΔpH m ( Figure 8A ). In addition, acetoacetate treatment to shift the mitochondrial NAD(P)H redox couple to a more oxidized state caused only a slight depression of the vasopressin-induced increase in ΔpH m
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( Figure 8A ). Addition of β-hydroxybutyrate elevated ΔΨ m , but did not alter changes in ΔΨ m in response to vasopressin (not shown).
A key question is whether the vasopressin-induced changes in mitochondrial PMF are mediated through a Ca 2ϩ -dependent mechanism. Therefore, hepatocytes were pre-loaded with BAPTA-AM (40 μM) to block vasopressin-stimulated [Ca 2ϩ ] c responses, allowing us to monitor for Ca 2ϩ -independent effects of the agonist on mitochondrial PMF. The BAPTA loading protocol was only effective in 10-20% of hepatocytes, yielding either completely blocked ( Figure 9A Figure 9B ). However, in these cells, the rate of rise in ΔΨ m after vasopressin treatment was slow when compared with cells not loaded with BAPTA ( Figure 8B ) or when BAPTA loading had no effect on vasopressin- ] c and NAD(P)H were carried out in primary cultured hepatocytes loaded with a low level of fura-2. In (A), the ATP/ADP ratio was reduced by addition of the mitochondrial ATP synthetase inhibitor oligomycin (5 μg/ml; OL), whereas in (B) a high intramitochondrial ATP/ADP ratio was achieved by inhibition of the adenine nucleotide translocase with atractyloside (5 μg/ml; AT). Hepatocytes were pre-incubated with the inhibitors for 5 min prior to the addition of 50 nM vasopressin. Mean NAD(P)H responses were normalized to the fluorescence intensity obtained after the addition of rotenone (5 μg/ml) plus 10 mM β-hydroxybutyrate (not shown), and are representative of two or more experiments. Insert: the effects of oligomycin and atractyloside on vasopressin-induced increases in [Ca 2ϩ ] m measured in cultured hepatocytes transfected with mitochondrial-targeted aequorin. Figure 9A and B clearly illustrate that an elevation of [Ca 2ϩ ] c is a prerequisite for the vasopressin-evoked increase in ΔΨ m .
induced [Ca 2ϩ ] c responses (not shown). The data of
Further evidence that the increase in mitochondrial PMF is mediated through a Ca 2ϩ -dependent mechanism is shown in Figure 9C (Hajnóczky et al., 1995) . Figure 9C shows the mean [Ca 2ϩ ] c and mean ΔpH m responses, and Figure 9D shows the mean [Ca 2ϩ ] c and mean ΔΨ m responses after the addition of thapsigargin. Cellular responses were measured simultaneously in fura-2-and fluorescein-loaded hepatocytes or in fura-2-and TMREE-loaded hepatocytes, respectively. Thapsigargin treatment caused an immediate, slow rise in [Ca 2ϩ ] c , which remained elevated for the duration of the experiment ( Figure 9C and D) . Thapsigargin addition also stimulated a robust increase in both fluorescein and TMREE fluorescence, indicating a relative increase in total mitochondrial PMF ( Figure 9C and D) . In fluorescein-and fura-2-coloaded hepatocytes, there was a consistent delay of 30-4994 60 s between thapsigargin-induced [Ca 2ϩ ] c increases and the initiation of the increase in ΔpH m ( Figure 9C ). This delay in the ΔpH m response is similar to what we previously reported for thapsigargin-evoked changes in both NAD(P)H and [Ca 2ϩ ] m (Hajnóczky et al., 1995) . However, we did not observe such a clear-cut delay in the thapsigargin-evoked increase in ΔΨ m ( Figure 9D ). While we have not yet identified the site(s) at which calcium exerts its effect on PMF, the data shown in Figure 9 clearly demonstrate that increases in mitochondrial PMF are mediated through a Ca 2ϩ -dependent pathway. These data represent the first direct evidence that the total PMF is increased in intact cells after treatment with vasopressin.
In order to obtain a quantitative estimate of the changes in PMF, fluorescein fluorescence was expressed as a ratio to the minimal fluorescence values obtained after addition of uncoupler (1799) plus oligomycin at the end of each experiment. This fluorescence ratio is related directly to ΔpH m (Thomas et al., 1991) . TMREE fluorescence changes were normalized to the maximum and minimum fluorescence intensities obtained after addition of nigericin to hyperpolarize the mitochondrial inner membrane, followed by 1799 plus oligomycin to collapse the PMF ( Figure 8B ). Vasopressin stimulation induced an increase in TMREE fluorescence equal to 10 Ϯ 0.6% (n Ͼ100 cells from two [Ca 2ϩ ] c was measured using fura-2 while ΔpH m was monitored with fluorescein. Fluorescein fluorescence was normalized to the values obtained after the addition of the uncoupler 1799 (5 μg/ml) plus oligomycin (5 μg/ml) (UNC). This fluorescence ratio reports the relative changes in the ΔpH m (Thomas et al., 1991) . Addition of β-OH followed by acetoacetate (AA) to reduce and then oxidize mitochondrial NADH did not significantly affect the magnitude of the changes in ΔpH m . (B) Simultaneous measurements of [Ca 2ϩ ] c and ΔΨ m in cultured hepatocytes stimulated with 50 nM vasopressin. [Ca 2ϩ ] c was measured using fura-2 and ΔΨ m was monitored with TMREE. The TMREE fluorescence traces were normalized to a maximal range of ΔΨ m by first hyperpolarizing the mitochondrial inner membrane using the K ϩ /H ϩ ionophore nigericin (Nig), followed by collapse of ΔΨ m with the uncoupler 1799 (5 μg/ml) plus oligomycin (5 μg/ml) (UNC). The TMREE fluorescence intensities are expressed as a percentage of the fluorescence intensity difference between these two conditions. All traces represent the mean of changes observed in all cells in the imaging field. preparations) of the full range from uncoupler-depolarized to the maximal polarization with nigericin. Utilizing confocal microscopy and very low levels of laser excitation, the changes in ΔpH m and ΔΨ m could also be observed at the level of individual mitochondria ( Figure 10A and B, see also Figure 2E ). From confocal images similar to that shown in Figure 10A , the apparent ΔpH m can be calculated from the log of the ratio of the mitochondrial to cytosolic fluorescein fluorescence intensities, assuming a linear relationship between fluorescence and indicator concentration. Basal ΔpH m was estimated to be 0.29 Ϯ 0.01 pH units (n ϭ 4 cells, Ͼ600 mitochondria) and 0.43 Ϯ 0.01 pH units (n ϭ 5 cells, Ͼ1200 mitochondria) after vasopressin stimulation. This analysis probably underestimates the magnitude of ΔpH m , since the optical section used to acquire the confocal images probably extends to some degree beyond the volume expected to be occupied by 4995 the mitochondrial matrix space (see Loew et al., 1993) . The limitations of using confocal microscopy to determine dye distribution across a single mitochondrion were even more evident when ΔΨ m was calculated from the mitochondrial to cytosolic TMREE fluorescence ratio. For the cell shown in Figure 10B , the mean basal TMREE fluorescence ratio was 79, and this increased to 151 in the presence of vasopressin (n Ͼ700 mitochondria). This converts into a ΔΨ m of -114 mV under basal conditions and -130 mV after vasopressin stimulation. Basal ΔΨ m has been reported previously to be -160 mV in isolated hepatocyte suspensions and -145 mV in the intact perfused liver (Hoek et al., 1980; Soboll et al., 1992; Soboll, 1993) , suggesting that the resolution limitations in the confocal imaging approach may underestimate the absolute value of ΔΨ m . Nevertheless, these data clearly demonstrate that vasopressin increases both the ΔΨ m and ΔpH m components of the PMF in individual hepatocytes, and give an estimate of~20% for the magnitude of total PMF increase.
Discussion
The current study was undertaken to elucidate the mechanisms responsible for the complex pattern of mitochondrial redox changes in response to intracellular [Ca 2ϩ ] increases following vasopressin treatment of hepatocytes. We have used a mode of stimulation in which a simultaneous and sustained increase in [Ca 2ϩ ] c and a single transient spike of [Ca 2ϩ ] m occur in all the cells within a population of hepatocytes. This has allowed us to monitor the time course and extent of the subsequent downstream mitochondrial events. The ionic and metabolic changes occurring in the mitochondria after stimulation with a high concentration of vasopressin fall into three phases (Figures 1, 4 and 8) . During the first phase, from 0 to 25 s (phase I), there is a rapid increase in [Ca 2ϩ ] m , followed after a 2-3 s lag by an increase in NAD(P)H ( Figure 1A and B) . This presumably reflects the Ca 2ϩ -dependent activation of PDH ( Figure 1B and C) and the citric acid cycle dehydrogenases, NAD ϩ -ICDH and OGDH. During phase I, there is also a decrease in cellular ATP levels, which remain depressed from~30 s after stimulation ( Figure 4A ). During the next phase (phase II, 25-60 s after stimulation), [Ca 2ϩ ] m returns to basal levels ( Figures 1A and 2F) . PDH a and NAD(P)H levels remain relatively stable during this phase. In phase III (60 s and later), NAD(P)H levels decay back to basal by~400 s after vasopressin addition ( Figure 1B ), while PDH a increases to a stable plateau over a similar time frame ( Figure 1B and C) . Increases in ΔpH m and ΔΨ m are initiated after the peak [Ca 2ϩ ] c rise and continue through phase III, reaching a peak value~600 s after the start of the [Ca 2ϩ ] c response (Figures 8 and 10 ). Both ΔpH m and ΔΨ m gradually return to baseline values during prolonged stimulation.
The data presented here provide a number of important insights into the mechanism of Ca 2ϩ signaling from cytosol to mitochondria, and how these signals are translated into the ultimate metabolic responses of the cell. We have used both fluorescent Ca 2ϩ indicators and targeted aequorins to confirm that [Ca 2ϩ ] m increases only transiently, even in the face of a sustained increase of [Ca 2ϩ ] c evoked by maximal vasopressin. This dissociation of Ca 2ϩ signals between the two compartments presumably reflects the privileged availability of Ca 2ϩ released from the ER for uptake by the mitochondria Hajnóczky et al., 1995; Rutter et al., 1996b) , which only occurs during the initial rapid phase of ER Ca 2ϩ release. The local [Ca 2ϩ ] c gradients underlying this privileged transfer of Ca 2ϩ to the mitochondria do not persist when the ER Ca 2ϩ stores are depleted at high levels of vasopressin (Hajnóczky et al., 1995) . The initial spike of [Ca 2ϩ ] m is sufficient to activate mitochondrial Ca 2ϩ -sensitive dehydrogenases, including an increase in PDH a , to generate a rapid rise in NAD(P)H. Nevertheless, the phosphorylation state of the PDH complex is clearly not the only determinant of the redox state of mitochondrial pyridine nucleotides. For example, manipulation of PDH a with DCA had rather limited effects on the pattern of NAD(P)H changes in response to vasopressin ( Figure 5) . Furthermore, the time dependences of the changes in NAD(P)H and PDH a following hormone stimulation were only linked in the early phase of the response (phase I; Figure 1 ). Therefore, increases in [Ca 2ϩ ] m correlate only with this initial phase of PDH activation. Subsequently, PDH a continued to rise despite the decline of [Ca 2ϩ ] m to basal levels (phases II and III). The secondary increase in PDH a is largely attributable to changes in the levels of two intramitochondrial metabolites, ATP and NADH, which are also regulators of the dehydrogenases that are allosterically regulated by [Ca 2ϩ ] m (NAD ϩ -ICDH and OGDH). The decrease in cellular ATP is likely to be due to the activation by vasopressin of cytosolic ATP-requiring processes (e.g. gluconeogenesis, Ca 2ϩ extrusion).
Despite the large and persistent activation of PDH by vasopressin, we observed that the increase in NAD(P)H levels was not sustained, but declined during phase III of the response. The fall in ATP levels could contribute to the decline in NAD(P)H, because a lower ATP:ADP ratio is expected to enhance flux through the respiratory chain. However, the changes in [ATP] occurred more rapidly than the decline of NAD(P)H (compare Figures 1 and 4) . Moreover, if the respiratory chain was stimulated by the lower level of ATP, this should have been accompanied by a fall in PMF. Instead, we observed an increase in both the ΔΨ m and ΔpH m components of the PMF. Taken together with the declining NAD(P)H level, the increase in PMF indicates that vasopressin treatment led to a direct stimulation of respiratory chain activity. While we cannot at this stage identify the site(s) at which Ca 2ϩ acts, our data indicate that Ca 2ϩ mobilization is absolutely required for vasopressin to augment the PMF (Figure 9 ). Furthermore, thapsigargin can also elevate the PMF, strengthening the concept that Ca 2ϩ ions mediate the increase in PMF (Figure 9 ). There have been a number of previous studies demonstrating increased respiratory chain activity or increases in PMF components in isolated mitochondria obtained from animals or cells treated with hormones such as glucagon, vasopressin and triiodothyronine. However, the present work represents the first direct demonstration of a hormone-induced increase in PMF measured in intact cells. Moreover, our ability to make these measurements at the single cell level has allowed us to define how the changes in PMF relate to the [Ca 2ϩ ] c and [Ca 2ϩ ] m signals generated by vasopressin treatment. The PMF components return to baseline values slowly after high vasopressin stimulation, even though the increase in [Ca 2ϩ ] m is more transient. It should also be noted that the increased mitochondrial PMF should have important effects on mitochondrial Ca 2ϩ uptake during oscillatory [Ca 2ϩ ] c signaling, since the initial rate of Ca 2ϩ uptake in hepatic mitochondria is proportional to the magnitude of the ΔΨ m (Gunter et al., 1994) . This suggests that not only can [Ca 2ϩ ] c signals regulate mitochondrial function but, once activated, the mitochondria are poised to modify subsequent incoming Ca 2ϩ signals. Thus, the progressive enhancement of mitochondrial Ca 2ϩ uptake could act to reduce the [Ca 2ϩ ] c in the vicinity of the mitochondria.
A number of previous studies have used cell suspensions and isolated mitochondria to investigate the mechanism by which Ca 2ϩ -dependent hormones activate the respiratory chain. Halestrap and co-workers have obtained evidence that respiratory chain activation occurs at the level of electron flow into the ubiquinone pool (Halestrap and Dunlop, 1986; Quinlan and Halestrap, 1986; Halestrap, 1989) . These workers suggested that this results from an increase in mitochondrial volume, which is mediated by a [Ca 2ϩ ] m -dependent accumulation of inorganic pyrophosphate (Davidson and Halestrap, 1987; Halestrap, 1989) . However, our studies indicate that respiratory chain activation continues despite the return of [Ca 2ϩ ] m to basal levels. This apparent hysteresis could reflect the time required for the accumulation of pyrophosphate to trigger a mitochondrial volume increase. It is also possible that the transient increase in [Ca 2ϩ ] m generates another, long lasting intramitochondrial signal to activate the respiratory chain. Alternatively, respiratory chain activity may be partially regulated by [Ca 2ϩ ] c levels.
In summary, changes in NAD(P)H levels following vasopressin stimulation and the accompanying single spike in [Ca 2ϩ ] m result from a complex interplay between several processes. These include the early activation of the mitochondrial dehydrogenases by Ca 2ϩ , followed later by increases in respiratory chain activity. Our data provide a molecular explanation for the dynamic changes in PDH a following vasopressin stimulation, involving a transient increase in [Ca 2ϩ ] m and subsequent alterations in ATP and NADH levels that further activate the enzyme. Similarly, the reoxidation of the NAD(P)H couple occurring in phase III of the response to vasopressin can be attributed to the activation of the respiratory chain, manifest as an increase in both the ΔΨ m and ΔpH m components of the PMF. Thus, the integrated metabolic response to Ca 2ϩ -dependent hormones includes stimulation of both the supply of respiratory substrates and flux through the respiratory chain, concomitant with the increase in metabolic energy demand for anabolic pathways such as gluconeogenesis. In addition to its role in signal transduction from cell surface receptors to the cytoplasm, Ca 2ϩ also functions in the transduction of signals from the cytosol to the mitochondria to allow concerted regulation of cellular metabolism.
Materials and methods
Hepatocyte isolation and culture
Hepatocytes were isolated by a two-step collagenase perfusion of livers from fed male Sprague-Dawley rats essentially as described by Rooney et al. (1989) , with the following modifications. Rat livers were perfused with the collagenase-containing buffer until fissures formed underneath the liver capsule when subjected to gentle pressure. The liver was minced, resuspended in the collagenase buffer supplemented with 1 mM CaCl 2 and incubated for an additional 5 min in a shaking water bath. Hepatocytes were washed, then plated on poly-D-lysine (5 μg/cm 3 )-coated glass coverslips or 35 mm plastic Petri dishes and maintained in primary culture for 1.5-3 h in Williams' E medium (WEM) plus 10% fetal calf serum (FCS) as described by Hajnóczky et al. (1995) . Hepatocytes used in confocal imaging experiments were cultured overnight in WEM supplemented with insulin. Prior to use, the cells were washed then preincubated for 40-60 min in KR-HEPES buffer composed of (in mM): 121 NaCl, 25 Na-HEPES, 5 NaHCO 3 , 4.7 KCl, 1.2 KH 2 PO 4 , 1.2 MgSO 4 , 2.0 CaCl 2 , 10 glucose, 3 L-lactate, 0.3 pyruvate and 0.25% (w/v) essentially fatty acid-free bovine serum albumin (BSA; Sigma fraction V), pH 7.4 at 37°C. When stated in the text, 2 mM D-carnitine or 2 mM L-carnitine were also present during the pre-incubation period. [Ca 2ϩ ] c was measured using fura-2 essentially as described previously (Rooney et al., 1989; Hajnóczky et al., 1995) . Briefly, primary cultured hepatocytes on glass coverslips were loaded with 5 μM fura-2 AM (TEFLABS, Austin, TX) for 20-30 min in the presence of 100 μM bromosulfophthalein (BSP) and 0.01% (w/v) pluronic acid F-127. BSP, a competitive anion transport inhibitor, was included to inhibit loss of the Ca 2ϩ indicator dye. BSP did not affect viability or inhibit [Ca 2ϩ ] c responses. When [Ca 2ϩ ] c was measured alone, fura-2-loaded hepatocytes were washed twice with KR-HEPES without dye or pluronic acid and transferred to a thermostatically regulated microscope chamber (37°C). Fluorescence images were acquired with a cooled charge-coupled device (CCD) camera under computer control and alternating excitation at 340 and 380 nm, as described previously (Rooney et al., 1989; Hajnóczky et al., 1995) . Simultaneous measurement of [Ca 2ϩ ] c and NAD(P)H was performed in hepatocytes loaded with low levels of fura-2 AM, as described by Hajnóczky et al. (1995) , except that BSP was used instead of sulfinpyrazone. The 360 nm fluorescence intensity or NAD(P)H signal was corrected for spillover from the Ca 2ϩ -free form of fura-2 and photobleaching. Fura-2 fluorescence spillover was corrected by subtracting a fraction of the 380 nm fluorescence intensity signal from the 360 nm signal (Chiavaroli et al., 1994) . The correction factor was determined from the ratio of the fluorescence decrease in the 360 nm signal to the fluorescence decrease in the 380 nm signal during an increase in [Ca 2ϩ ] c . A separate correction factor was determined for each individual experiment. Photobleaching rate was corrected for by fitting a single exponential to the baseline 360 nm fluorescence signal. The best fit exponential equation was used to construct a separate trace that described the photobleaching rate over the time course of the experiment. This trace was then added to the 360 nm fluorescence 4998 intensity to give a corrected NAD(P)H trace. When NAD(P)H was measured separately from [Ca 2ϩ ] c , the 360 nm fluorescence signal was corrected only for photobleaching. To measure [Ca 2ϩ ] c and [Ca 2ϩ ] m simultaneously, hepatocytes were co-loaded with fura-2 AM and dihydrorhod-2 AM as described in Hajnóczky et al. (1995) . Fura-2 and rhod-2 fluorescence images were acquired by alternating excitation at 380 nm (fura-2) and 548 nm (rhod-2). The emitted fluorescence was collected using a fura-2/rhodamine dichroic beamsplitter and emission filter set (Chroma Technology). Fura-2 and fluorescein fluorescence images were acquired by alternating excitation at 340, 380 and 495 nm using a computer-controlled filter wheel and shutter. The emitted fluorescence was collected using a fura-2/BCECF dichroic beamsplitter and a 515 nm long band pass emission filter (Chroma Technology). Fluorescein fluorescence contaminates the fura-2 fluorescence intensity signal to a small extent, so conversion of the fura-2 ratio into [Ca 2ϩ ] c was not possible. When [Ca 2ϩ ] c and ΔΨ m were measured simultaneously, fura-2-loaded hepatocytes were preincubated for 60 min in a KR-HEPES buffer containing 5 nM TMREE prior to transferring both coverslip and TMREE-containing buffer to the microscope chamber. This pre-incubation was necessary to allow TMREE to reach equilibrium across the mitochondrial membrane. In the presence of BSP, no significant loss of fura-2 fluorescence was noted during the pre-incubation. Fura-2 and TMREE fluorescence images were acquired by alternating excitation at 340, 380 and 548 nm. The emitted fluorescence was collected as described above. Values for [Ca 2ϩ ] c were calculated from the 340/380 nm ratio after correction for autofluorescence. Autofluorescence values were obtained at the end of each experiment by permeabilizing the hepatocytes with digitonin (20 μg/ml) in an intracellular-like medium containing Ca 2ϩ /EGTA buffer and 2 mM ATP·Mg. The fura-2 calibration parameters were determined in vitro using a K d value of 224 nM. Under these experimental conditions, the fura-2 and TMREE fluorescence intensity signals did not overlap, nor was there any effect of TMREE on the calculated [Ca 2ϩ ] c values. The TMREE fluorescence intensity was calibrated at the end of each experiment by the addition of 1 μM nigericin, to hyperpolarize the mitochondrial inner membrane, followed by the uncoupler, 1799, plus oligomycin (5 μg/ml each) to obtain the minimum fluorescence values. Oligomycin was included to block uncoupler-stimulated ATP hydrolysis. The addition of the solvent, dimethylsulfoxide (DMSO), to TMREEloaded hepatocytes causes a small but significant increase in the 548 nm fluorescence signal in the absence of any [Ca 2ϩ ] c changes. The subsequent addition of Ca 2ϩ -mobilizing agents results in a larger increase in 548 nm fluorescence on top of that observed with DMSO alone (data not shown). The addition of DMSO to fluorescein-loaded hepatocytes had no effect on 495 nm fluorescence intensity (data not shown). Thus, it appears that DMSO has a non-specific effect on TMREE fluorescence which is unrelated to ΔΨ m .
Imaging measurements of [Ca 2⍣ ] c , [Ca 2⍣ ] m and NAD(P)H
Laser scanning confocal microscopy
For simultaneous measurement of MTG (Molecular Probes) and rhod-2 fluorescence, overnight-cultured hepatocytes were incubated with 200 nM MTG for 60 min in WEM plus 10% serum supplemented with 0.005% pluronic acid F-127. The cells were washed and then loaded for 10 min with rhod-2 AM (10 μM) at room temperature in a KR-HEPES buffer plus 0.01% pluronic acid F-127. After loading, the cells were washed extensively with KR-HEPES containing pluronic acid to remove the AM dye prior to switching to a buffer without pluronic acid. Confocal images were acquired using a Bio-Rad MRC 600 laser scanning confocal microscope equipped with a 25 mW argon ion laser. The two dyes were excited simultaneously using the 514 nm laser line, and the emitted red and green fluorescence was collected by separate photomultiplier tubes using the Bio-Rad MRC 600 software and filter sets. The optical section was Ͻ1 μm thick.
High resolution measurements of ΔpH m were performed in overnightcultured hepatocytes. Hepatocytes were loaded with 200 nM fluorescein diacetate for 40 min in KR-HEPES buffer at room temperature and then washed for 30 min. Confocal images of fluorescein-loaded hepatocytes were acquired with 488 nm excitation and a 515 nm long band pass emission filter. Since fluorescein was very sensitive to bleaching, the laser excitation light was attenuated to Ͻ0.5% transmission. Mitochondrial membrane potential was measured in overnight-cultured hepatocytes pre-incubated for 60-90 min at room temperature in a KR-HEPES buffer containing 5 nM TMREE. Confocal images of TMREE-loaded hepatocytes were acquired using 514 nm excitation and a 600 nm long band pass emission filter. Laser intensity was attenuated to 1% transmission.
Plasmid construction
cDNAs encoding the N-terminus of cytochrome c oxidase (subunit VIII), an HA epitope tag and aequorin (Rutter et al., 1996) were subcloned in-frame into the cytomegalovirus (CMV) immediate early promoterbased expression vector VR1012 (Vical, San Diego, CA; plasmid pCMV*Aq m ). A plasmid encoding untargeted aequorin (pCMV*Aq c ) was constructed by omitting cytochrome c oxidase cDNA. Plasmid DNA was purified on two consecutive CsCl gradients, as described by Sambrook et al. (1989) .
Transfection of hepatocytes
Primary rat hepatocytes were isolated as described above and resuspended at 1.0 ϫ10 6 cells/ml in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS and antibiotics as described by Rutter et al. (1996a) for distribution onto poly-D-lysine-coated glass coverslips (13 mm diameter). After culture for 3 h at 37°C, the medium was aspirated carefully and replaced with 1 ml of serum-free medium containing 1 μg of DNA and 2.5 μl of Tfx-50™ (Promega) as per the manufacturer's instructions. After a further 2 h incubation, an additional 1 ml of medium containing 10% serum, was added, and the cells incubated for 24-48 h at 37°C. This method of transfection provided 1.0% efficiency, as assessed by immunostaining for the transfected aequorin chimera (see below).
Assay of aequorin luminescence and calibration of signals
Expressed aequorin was reconstituted to form the active holoenzyme by incubating transfected hepatocytes for 2 h in serum-free DMEM supplemented with 5 μM coelenterazine (Molecular Probes). Luminescence from cell populations was measured using a low noise photomultiplier (PM) system, with the cells placed in a thermostatted chamber (37°C) maintained 3 mm from the PM tube window (Rutter et al., 1993) . Cells were superfused constantly (2.5 ml/min) with BSA-free KR-HEPES buffer (see above), and stimuli added by rapidly switching the superfusion medium. At the end of each run, total aequorin was determined by hypotonic cell lysis in the presence of 10 mM CaCl 2 , 0.1 mg/ml digitonin (Rutter et al., 1993) . Collected data (1 data point/ s) were stored and analyzed off-line using EXCEL™ (Microsoft) to obtain free [Ca 2ϩ ] from a look-up table as described previously (Rutter et al., 1993; Brini et al., 1995) Immunocytochemistry Transfected cells were fixed with paraformaldehyde and probed with a monoclonal antibody (12CA6) to the HA tag as described by Brini et al. (1994) . Immunolabeling was revealed with a tetramethylrhodamine isothiocyanate-labeled anti-mouse IgG antibody. Confocal images were obtained using a laser scanning confocal microscope (Leica DM RBE), fitted with a 63ϫ1.3 NA oil-immersion objective with excitation using the 568 nm laser line. Image reconstitution was performed using Imaris™ software on a Silicon Graphics workstation.
Measurement of pyruvate dehydrogenase activity
Hepatocytes plated on Petri dishes were maintained in primary culture for 90 min. The cells were washed twice in KR-HEPES buffer without BSA and once with BSA-containing media. Washed hepatocytes were pre-incubated for 45 min in KR-HEPES buffer at 34°C. This temperature is the approximate buffer temperature in our thermostatically regulated microscope chamber set to 37°C. The buffer was aspirated quickly, and 3 ml of warmed buffer containing the required additions was gently pipetted onto the cells. Incubations were terminated by aspirating the buffer and quickly immersing the Petri dishes into liquid N 2 . Ice-cold extraction buffer [100 mM KH 2 PO 4, 1 mM Na-EDTA, 5% (v/v) fetal calf serum, 1 mM dithiothreitol, 0.1% Triton X-100, 1 μg/ml of the proteinase inhibitors pepstatin A, antipain and leupeptin, pH 7.3; 150 μl] was then added to the Petri dish on ice, and the cells extracted by scraping. The extracted material was frozen and thawed twice more, to ensure complete disruption of mitochondria, and clarified by centrifugation (10 000 g, 1 min, 4°C) before the assay of initial and total PDH activity as described previously (McCormack, 1985; Rutter et al., 1996b) .
Determination of cellular ATP levels
Hepatocytes were prepared, plated and incubated according the method described above for the determination of PDH activity. After experimental manipulation, cells were extracted with ice-cold perchloric acid (10% v/v, 200 μl), rapidly frozen and stored at -80°C. Determination of ATP was based on published procedures (Stanley and Williams, 1969; Owen and Halestrap, 1993) . Briefly, samples were thawed and adjusted to pH 7.4 with a known volume of neutralization mixture (0.5 M triethanolamine, 2 M KOH, 100 mM EDTA). Potassium perchlorate precipitate was removed by centrifugation (10 000 g, 2 min) and the supernatant stored on ice prior to assay. Neutralized sample (10 μl) was added to 1 ml of assay buffer (130 mM NaHAsO 4 , 17 mM MgSO 4 , 4 mM NaH 2 PO 4 , pH 7.4) and the reaction was initiated with 10 μg of firefly lantern extract (Sigma, Poole, UK). Emitted light was recorded for 30 s using a photon counting luminometer (LB-9501; EG & Berthold, Bad Wildbad, Germany). Values for cellular ATP (pmoles) were obtained by comparison with known ATP standards (0-20 pmol) prepared in parallel. Protein content was determined in a parallel cell culture by Bradford assay (Bradford, 1976) Statistical analysis Data are given as means Ϯ SEM for the number of separate hepatocyte cultures shown in parentheses. Unless otherwise stated in text, all experiments were repeated with at least three separate hepatocyte preparations.
